Drug Repurposing and Combination Therapy Development Milestones
7.A-7.F
Selected filters
No filters selected
Filter
6 Results
ID
Title
Status
7.A
Drug Repurposing: Multiscale models of disease
7.A
Drug Repurposing: Multiscale models of disease
Expand existing and develop new systems biology and systems pharmacology research programs...
Status
Achieved
7.B
Drug Repurposing: Translational bioinformatics and network pharmacology
7.B
Drug Repurposing: Translational bioinformatics and network pharmacology
Initiate research programs for translational bioinformatics and network pharmacology...
Status
Achieved
7.C
Drug Repurposing: Data-driven drug repositioning and combination therapy
7.C
Drug Repurposing: Data-driven drug repositioning and combination therapy
Continue to develop resources, capabilities and partnerships to advance data-driven drug repositioning and combination therapy...
Status
In Progress
7.D
Drug Repurposing: Early clinical development
7.D
Drug Repurposing: Early clinical development
Initiate early clinical development for at least 6 existing drugs or drug combinations for the treatment or prevention of AD and AD-related dementias.
Status
In Progress
7.E
Drug Repurposing: Phase 3 trials
7.E
Drug Repurposing: Phase 3 trials
Initiate at least three Phase 3 trials with repurposed drugs or drug combinations...
Status
In Progress
7.F
FTD: Treatments for FTD
7.F
FTD: Treatments for FTD
Accelerate pre-clinical disease-modifying and symptomatic therapeutic development in FTD.
Status
In Progress